{"filing":{"accession_number":"0001654954-26-005964","cik":"0000901832","ticker":"AZN","company_name":"ASTRAZENECA PLC","form":"6-K","filing_date":"2026-06-15","report_date":null,"primary_document":"a1987i.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/901832/000165495426005964/a1987i.htm"},"events":[{"id":12293,"run_id":10859,"accession_number":"0001654954-26-005964","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"This 6-K discloses FDA approval of Truqap (capivasertib) in combination with abiraterone and prednisone for PTEN-deficient metastatic prostate cancer, based on positive Phase III CAPItello-281 trial results showing a 19% reduction in risk of disease progression or death. This is a material regulatory milestone and product approval event that expands AstraZeneca's oncology portfolio into a second tumor type, representing a significant operational and commercial development rather than a discrete financial, governance, or legal event.","company_name":"ASTRAZENECA PLC","ticker":"AZN","filing_date":"2026-06-15","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":9106,"accession_number":"0001654954-26-005964","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"This 6-K discloses FDA approval of Truqap (capivasertib) in combination with abiraterone and prednisone for PTEN-deficient metastatic prostate cancer, based on positive Phase III CAPItello-281 trial results showing a 19% reduction in risk of disease progression or death. This is a material regulatory milestone and product approval event that expands AstraZeneca's oncology portfolio into a second tumor type, representing a significant operational and commercial development rather than a discrete financial, governance, or legal event.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:34:38.770446+00:00","company_name":"ASTRAZENECA PLC","ticker":"AZN","filing_date":"2026-06-15"}]}